Quizalize logo
placeholder image to represent content

HIV Drugs

Quiz by Abby Bennett

Feel free to use or edit a copy

includes Teacher and Student dashboards

Measure skills
from any curriculum

Tag the questions with any skills you have. Your dashboard will track each student's mastery of each skill.

With a free account, teachers can
  • edit the questions
  • save a copy for later
  • start a class game
  • automatically assign follow-up activities based on students’ scores
  • assign as homework
  • share a link with colleagues
  • print as a bubble sheet

Our brand new solo games combine with your quiz, on the same screen

Correct quiz answers unlock more play!

New Quizalize solo game modes
38 questions
Show answers
  • Q1

    HIV-2 is localized in West Africa and is less lethal

    true
    false
    True or False
    30s
  • Q2

    What percentage of the global population is HIV positive

    58%

    0.8%

    18%

    8%

    30s
  • Q3

    Which HIV subgroup is most common in North America

    HIV-1, group P (subtype B)

    HIV-1, group N (subtype B)

    HIV-1, group O (subtype B)

    HIV-1, group M (subtype B)

    30s
  • Q4

    Which viral classification does HIV fall in?

    Group V

    Group IV

    Group VII

    Group VI

    30s
  • Q5

    HIV targets and kills which key cell in the adaptive immune response

    NK Cell

    CD4 Helper T Cell

    B Cell

    CD8 Killer T Cell

    30s
  • Q6

    HIV can remain latent for years. As such, drug treatment extends the latency period and reduces transmissibility.

    true
    false
    True or False
    30s
  • Q7

    Which of the following is NOT an opportunistic infection associated with HIV

    Lymphoma/Kaposi's Sarcoma

    Influenza/Rhinovirus

    Thrush/Candida Esophagitis/HSV Esophagitis

    Microsporidiosis/Cryptosporidiosis/Mycobacterium avium/CMV

    30s
  • Q8

    Which is the correct order of the HIV lifecycle

    Proteolysis, Release, Assembly, Integration, Reverse Transcriptase, Fusion/Entry

    Fusion/Entry, Integration, Assembly, Reverse Transcriptase, Proteolysis, Release

    Fusion/Entry, Reverse Transcriptase, Integration, Assembly, Release, Proteolysis

    Fusion/Entry, Proteolysis, Reverse Transcriptase, Assembly, Integration, Release

    30s
  • Q9

    Protease Inhibitors

    Raltegravir

    Ritonavir

    Emtricitabine, Tenofovir

    Enfuvirtide, Maraviroc

    30s
  • Q10

    Entry/Fusion Inhibitors

    Efavirenez, Nevirapine

    Enfuvitide, Maraviroc

    Emtricitabine, Tenofovir

    Raltegravir

    30s
  • Q11

    Reverse Transcriptase Inhibitors - Nucleoside (NRTI)

    Raltegravir

    Ritonavir

    Emtricitabine, Tenofovir

    Efavirenez, Nevirapine

    30s
  • Q12

    Reverse Transcriptase Inhibitors - Non-Nucleoside (NNRTI)

    Raltegravir

    Ritonavir

    Efavirenez, Nevirapine

    Emtricitabine, Tenofovir

    30s
  • Q13

    Integrase Inhibitors

    Ritonavir

    Emtricitabine, Tenofovir

    Raltegravir

    Efavirenez, Nevirapine

    30s
  • Q14

    Entry/Fusion Inhibitor MOA

    Blocks entry/fusion of HIV to the CD4 receptors

    Blocks entry/fusion of HIV  into the body

    Blocks entry/fusion of HIV into  the nucleus of a CD4 cell

    Blocks entry/fusion of HIV into the epithelial cells

    30s
  • Q15

    Entry/Fusion Toxicities

    None

    Fatigue

    Headache

    Nausea/Vomiting

    30s

Teachers give this quiz to your class